James Parslow - Jun 18, 2024 Form 4 Insider Report for Xenetic Biosciences, Inc. (XBIO)

Role
Interim CEO and CFO
Signature
/s/ James Parslow
Stock symbol
XBIO
Transactions as of
Jun 18, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 05:00 PM
Previous filing
Dec 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XBIO Stock Options Award $0 +20K $0.00 20K Jun 18, 2024 Common Stock 20K $3.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options will vest and become exercisable as follows: one-fourth of the shares shall vest on the date of grant and one-fourth of the shares shall vest on each of the first, second and third anniversaries of June 18, 2024 ending on June 18, 2027.